STAT+: The last ‘breakthrough’ devices to get special treatment from Medicare
AI Summary
The FDA’s breakthrough-device designation no longer automatically grants new medical devices additional Medicare payments. The change alters the reimbursement pathway for devices receiving the designation.
New medical devices deemed "breakthrough" by the FDA are no longer automatically eligible for extra Medicare payments.